Levels of AGP have been measured in plasma samples from cancer patients, and significantly elevated levels of AGP have been reported in them when compared with those in healthy controls and benign diseases resulting in the proposal as a tumor marker [8,19,20]. The gene discussed is ATP5MK; the disease is neoplasm.